Webinar Oncolines: Biomarkers for Patient Stratification & Target Engagement
Despite significant advances made in the treatment of cancer through the past decades, many new therapeutic entities fail in the clinical research phase. To accelerate your drug development process and improve patient treatment, the identification of relevant biomarkers is of key importance. Among the different types of biomarkers, predictive drug response biomarkers allow for definition of the target patient population, whereas pharmacodynamic biomarkers can aid in monitoring of drug target engagement.